Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|October 18, 2025
Dynamic changes in IGF-1 levels during cabergoline therapy in prolactinomaAhmet Numan Demir, Alara Birol, Dilan Ozaydin, et al.
Frontiers in Endocrinology|February 16, 2026
Predicting resection success in giant pituitary adenomas: morphologic determinants and a preoperative multivariate modelDilan Ozaydin, Ender Vergili, Alperen Kaya, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|January 10, 2025
A Case Report of Recurrent Primary Pituitary Abscess: Challenges in Diagnosis and TreatmentDilan Ozaydin, Ahmet Numan Demir, Tufan Agah Kartum, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|July 11, 2024
Role of Medical and Surgical Treatment in Management of the Patients With Prolactinoma: A Single-Center ExperienceGuldana Zulfaliyeva, Ahmet Numan Demir, Semih Can Cetintas, et al.
Scientific Reports|December 12, 2025
Ustekinumab may have therapeutic effects on autoimmune thyroid diseaseSuleyman Sami Guzel, Ahmet Numan Demir, Tugce Eskazan, et al.
Obesity Facts|August 3, 2022
Risk Factors Influencing Seroconversion after Inactive SARS-CoV-2 Vaccination in People Living with ObesityZehra Kara, Rüveyda Akçin, Ahmet Numan Demir, et al.
Obesity Facts|May 26, 2023
Antibody Response to Inactive SARS-CoV-2 Vaccination in a Cohort of Elderly Patients Living with ObesityZehra Kara, Rüveyda Akçin, Ahmet Numan Demir, et al.
Obesity Surgery|July 8, 2022
Antibody Response to SARS-CoV-2 Vaccines in People with Severe ObesityZehra Kara, Rüveyda Akçin, Ahmet Numan Demir, et al.
Frontiers in Endocrinology|March 30, 2026
Life activities of elderly patients with operated nonfunctional pituitary adenomaZehra Kara, Suna Avci, Seçil Erden Melikoglu, et al.
World Neurosurgery|April 29, 2023
The Combination of Dopamine Agonist Treatment and Surgery May Be the Best Option in Challenging Prolactinoma Cases: A Single-Centre ExperienceDilan Demir, Ahmet Numan Demir, Cem Sulu, et al.
Pageof 4